Robert Wong, MD
Ophthalmology · Austin, TXNPI 1275699274
Payments from drug & device makers
Across 1,736 payments — averaging $3807.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$3.4M
- Bayer$1M
- Regeneron$975K
- Ocular Therapeutix, Inc.$722K
- Kyowa Kirin, Inc.$202K
- Boehringer Ingelheim International GmbH$113K
- plus $139K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 474 | $3,427,095 |
| Bayer | 363 | $1,031,781 |
| Regeneron | 375 | $975,052 |
| Ocular Therapeutix, Inc. | 71 | $721,810 |
| Kyowa Kirin, Inc. | 68 | $202,237 |
| Boehringer Ingelheim International GmbH | 183 | $112,523 |
| Baxter Healthcare | 24 | $97,590 |
| Astellas Pharma Global Development | 4 | $17,643 |
| Eyepoint US, Inc. | 3 | $8,188 |
| US Retina LLC | 11 | $4,331 |
| Novartis | 5 | $3,370 |
| AbbVie(2 entities) | 14 | $1,072 |
| Regeneron Healthcare Solutions, Inc. | 35 | $1,051 |
| Novo Nordisk AS | 1 | $1,028 |
| Genentech USA, Inc. | 28 | $1,002 |
| Apellis Pharmaceuticals, Inc. | 19 | $782 |
| Alcon | 4 | $626 |
| Mallinckrodt Hospital Products Inc. | 14 | $400 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $381 |
| Astellas Pharma US Inc | 11 | $292 |
| Biotissue Holdings Inc. | 2 | $282 |
| Bausch & Lomb Americas Inc. | 5 | $195 |
| Carl Zeiss Meditec, Inc. | 1 | $176 |
| Alimera Sciences, Inc. | 2 | $155 |
| Optos, Inc. | 1 | $144 |
| ANI Pharmaceuticals, Inc. | 5 | $135 |
| Rxsight Inc | 1 | $127 |
| Amgen(2 entities) | 2 | $123 |
| Mallinckrodt Enterprises LLC | 1 | $119 |
| Optovue, Inc. | 1 | $100 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $60 |
| Dutch Ophthalmic, USA | 1 | $20 |
| Biogen | 1 | $13 |
| Travere Therapeutics, Inc. | 1 | $10 |
How this compares
$6,609,914 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Austin
- Chirag JhaveriAustin$9.4M
- Fuad MakkoukAustin$6.6M
- Shelley GhafooriAustin$2.9M
- Thomas WaltersAustin$2.4M
- Philip StoreyAustin$2.1M
- Saradha ChexalAustin$1.8M
- James DoonerAustin$556K
- Charles WykoffBellaire$73.4M
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.